Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PEGVORHYALURONIDASE ALFA Cause Hypernatraemia? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Hypernatraemia have been filed in association with PEGVORHYALURONIDASE ALFA. This represents 21.9% of all adverse event reports for PEGVORHYALURONIDASE ALFA.

7
Reports of Hypernatraemia with PEGVORHYALURONIDASE ALFA
21.9%
of all PEGVORHYALURONIDASE ALFA reports
6
Deaths
7
Hospitalizations

How Dangerous Is Hypernatraemia From PEGVORHYALURONIDASE ALFA?

Of the 7 reports, 6 (85.7%) resulted in death, 7 (100.0%) required hospitalization.

Is Hypernatraemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PEGVORHYALURONIDASE ALFA. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does PEGVORHYALURONIDASE ALFA Cause?

Diarrhoea (11) Fatigue (11) Ascites (9) Agitation (8) Aspartate aminotransferase increased (8) Blood alkaline phosphatase increased (8) Dyspnoea (8) Nausea (8) Pyrexia (8) Vomiting (8)

What Other Drugs Cause Hypernatraemia?

TOLVAPTAN (235) FUROSEMIDE (192) LITHIUM (186) SODIUM (136) LAMOTRIGINE (90) VALPROIC ACID (88) OLANZAPINE (87) METFORMIN (79) QUETIAPINE (77) ARIPIPRAZOLE (69)

Related Pages

PEGVORHYALURONIDASE ALFA Full Profile All Hypernatraemia Reports All Drugs Causing Hypernatraemia PEGVORHYALURONIDASE ALFA Demographics